Bion Julian
Crit Care. 2013 Dec 19;17(6):1025. doi: 10.1186/cc13165.
Barriers to the use of selective digestive decontamination include concerns about emergence of resistant organisms, over-estimation of current performance in preventing ventilator-associated pneumonia (VAP), alternative methods of preventing VAP, and misunderstanding of mechanisms of action. A definitive cluster-randomised trial should be undertaken that incorporates practitioner concerns and effect-size preferences.
选择性消化道去污使用的障碍包括对抗药微生物出现的担忧、对当前预防呼吸机相关性肺炎(VAP)效果的高估、预防VAP的替代方法以及对作用机制的误解。应该进行一项纳入从业者担忧和效应量偏好的确定性整群随机试验。